These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7740757)

  • 21. A haemolytic cell-free preparation of Moraxella bovis confers protection against infectious bovine keratoconjunctivitis.
    Billson FM; Hodgson JL; Egerton JR; Lepper AW; Michalski WP; Schwartzkoff CL; Lehrbach PR; Tennent JM
    FEMS Microbiol Lett; 1994 Nov; 124(1):69-73. PubMed ID: 8001772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1985 May; 46(5):1011-4. PubMed ID: 2408520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves.
    Arora AK; Killinger AH; Mansfield ME
    Am J Vet Res; 1976 Jul; 37(7):803-5. PubMed ID: 937804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bovine infectious keratoconjunctivitis: serological aspects of Moraxella bovis infection.
    Pugh GW; Hughes DE; McDonald TJ
    Can J Comp Med; 1971 Apr; 35(2):161-6. PubMed ID: 4253466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens.
    Gerber JD; Selzer NL; Sharpee RL; Beckenhauer WH
    Vet Immunol Immunopathol; 1988 Feb; 18(1):41-52. PubMed ID: 3376421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of complete RTX operons in Moraxella bovoculi and Moraxella ovis.
    Angelos JA; Ball LM; Hess JF
    Vet Microbiol; 2007 Nov; 125(1-2):73-9. PubMed ID: 17561358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Q pili enhance the attachment of Moraxella bovis to bovine corneas in vitro.
    Ruehl WW; Marrs C; Beard MK; Shokooki V; Hinojoza JR; Banks S; Bieber D; Mattick JS
    Mol Microbiol; 1993 Jan; 7(2):285-8. PubMed ID: 8095318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of Moraxella bovis hemolysin.
    Clinkenbeard KD; Thiessen AE
    Infect Immun; 1991 Mar; 59(3):1148-52. PubMed ID: 1900058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of lipooligosaccharide in the biological activity of Moraxella bovis strains Epp63, Mb25 and L183/2, and isolation of capsular polysaccharide from L183/2.
    Singh S; Grice ID; Peak IR; Frost T; Yue G; Wilson JC
    Carbohydr Res; 2018 Sep; 467():1-7. PubMed ID: 30032028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attachment of Moraxella bovis to calf corneal cells and inhibition by antiserum.
    Moore LJ; Rutter JM
    Aust Vet J; 1989 Feb; 66(2):39-42. PubMed ID: 2565715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure of bovine cornea to different strains of Moraxella bovis and to other bacterial species in vitro.
    Chandler RL; Smith K; Turfrey BA
    J Comp Pathol; 1985 Jul; 95(3):415-23. PubMed ID: 4031135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).
    Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytopathic effects of Moraxella bovis on cultured bovine neutrophils and corneal epithelial cells.
    Kagonyera GM; George LW; Munn R
    Am J Vet Res; 1989 Jan; 50(1):10-7. PubMed ID: 2919815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Bdellovibrio bacteriovorus 109J for the treatment of dairy calves with experimentally induced infectious bovine keratoconjunctivitis.
    Boileau MJ; Mani R; Breshears MA; Gilmour M; Taylor JD; Clinkenbeard KD
    Am J Vet Res; 2016 Sep; 77(9):1017-28. PubMed ID: 27580114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis.
    Lepper AW; Moore LJ; Atwell JL; Tennent JM
    Vet Microbiol; 1992 Sep; 32(2):177-87. PubMed ID: 1359693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1984 Sep; 45(9):1848-51. PubMed ID: 6497144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of biofilm-forming capacity of Moraxella bovis, the primary causative agent of infectious bovine keratoconjunctivitis.
    Prieto C; Serra DO; Martina P; Jacobs M; Bosch A; Yantorno OM
    Vet Microbiol; 2013 Oct; 166(3-4):504-15. PubMed ID: 23907059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Descriptive epidemiology of Moraxella bovis, Moraxella bovoculi and Moraxella ovis in beef calves with naturally occurring infectious bovine keratoconjunctivitis (Pinkeye).
    O'Connor AM; Shen HG; Wang C; Opriessnig T
    Vet Microbiol; 2012 Mar; 155(2-4):374-80. PubMed ID: 21962410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.